Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669629 · ClinicalTrials.gov registry record · NA
Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear
A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
- 10
- Study locations
NCT01669629: Completed NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
NCT01669629 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 183 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (31% lower). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01669629, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a one week 2x2 crossover study comparing delefilcon A with etafilcon A, with a primary hypothesis of comparing the handling of each lens. Additional secondary markers are measured looking at subjective comfort and vision of the lenses.
Primary Outcome
Measured on a 5 point-scale of excellence (excellent, very good, good, fair and poor) per a participant. Outcome is reported as aggregate number of subjects who reported Excellent/Very Good at their 1-week visit.
Conditions Studied
Interventions
- DEVICE delefilcon A
- DEVICE etafilcon A
Study Locations (10)
Arkansas
- - Little Rock
Connecticut
- - Bridgeport
Florida
- - Tampa
Missouri
- - Blue Springs
New York
- - Vestal
North Carolina
- - Raleigh
Pennsylvania
- - Kittanning
Rhode Island
- - Warwick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2012-08 |
| Est. Completion | 2012-11 |
| Phase | NA |
What the finished NCT01669629 record still lists
NCT01669629 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which delefilcon A is the first listed.
NCT01669629 lists 10 locations in 10 states (Arkansas, Connecticut, Florida).
Frequently Asked Questions
What is clinical trial NCT01669629 about?
NCT01669629 is a clinical study titled "Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear". This is a one week 2x2 crossover study comparing delefilcon A with etafilcon A, with a primary hypothesis of comparing the handling of each lens. Additional secondary markers are measured looking at subjective comfort and vision of the lenses.
What is the current status of trial NCT01669629?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2012-08. Estimated completion is 2012-11.
What conditions does trial NCT01669629 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01669629?
The interventions under investigation include: delefilcon A (DEVICE), etafilcon A (DEVICE).
Who is sponsoring clinical trial NCT01669629?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01669629 being conducted?
This trial has 10 study locations across Arkansas, Connecticut, Florida, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01669629's enrollment target sits among peer trials
183 26th of 90 higher than 65 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia